Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

Introduction to high-performance liquid chromatography-tandem mass spectrometry: The gold standard for monitoring immunosuppressive drugs

P. J. Taylor

Ann Transplant 2008; 13(1): 18-18 :: ID: 880172


Many of the immunosuppressive drugs require monitoring to provide optimal and individualised therapy for patients who have undergone solid organ transplantation. Clinical laboratories have the choice of methodology used for these drug analyses and this choice may impact on the quality of pharmacokinetic data provided to the transplant physician. The majority of laboratories use either high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) or antibody-based immunoassays. Most of the measured immunosuppressive drugs are neutral in nature and would appear unsuited to the ionisation processes of HPLC-MS/MS. However, ionisation of these compounds can be achieved by the addition of modifiers, such as
ammonium acetate, to the mobile phase which promote adduct formation. The use of successive (tandem) mass analysers provides for high selectivity and sensitivity which is required for the measurement of the more potent drugs (i.e. tacrolimus, sirolimus and everolimus) and simplifies the chromatographic separation. Thus making this technique highly suited to the clinical requirements for monitoring these drugs. While immunoassays are widely used for analysis of immunosuppressive drugs, there are several drawbacks to their use. Firstly, these methods tend to suffer from over-estimation in results due to the non-specific binding (to varying degrees) of metabolites with the assay antibody and have been shown to be influenced by the biochemical status of the patient, such as hematocrit. Secondly, some immunoassays have been shown to have poor accuracy and imprecision at the critical lower end of the therapeutic range. The aims of this presentation are to provide an overview on HPLC-MS/MS instrumentation, to discuss its use in the therapeutic drug monitoring of immunosuppressive drugs, and to provide a critical comparison with immunoassays.

Keywords: immunosuppressive drugs, Organ Transplantation, Bladder, cystofix, knotting.


In Press

06 May 2022 : Original article  

Phosphatidylethanol (PEth) for Monitoring Sobriety in Liver Transplant Candidates: Preliminary Results of D...

Ann Transplant In Press; DOI: 10.12659/AOT.936293  

27 Apr 2022 : Review article  

A Systematic Review of the Literature on Chronic Kidney Disease Following Liver Transplantation

Ann Transplant In Press; DOI: 10.12659/AOT.935170  

Most Viewed Current Articles

31 Dec 1969 : Original article  

Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...

DOI :10.12659/AOT.933588

Ann Transplant 2021; 26:e933588

31 Dec 1969 : Review article  

Recurrence of Hepatocellular Carcinoma After Liver Transplantation: Risk Factors and Predictive Models

DOI :10.12659/AOT.934924

Ann Transplant 2022; 27:e934924

31 Dec 1969 : Review article  

Kidney Transplantation in the Times of COVID-19 – A Literature Review

DOI :10.12659/AOT.925755

Ann Transplant 2020; 25:e925755

31 Dec 1969 : Case report  

Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...

DOI :10.12659/AOT.935860

Ann Transplant 2022; 27:e935860

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358